Evidence map›Paper›PMID 25210925›Full record

ArticlePLoS pathogens2014

Unravelling the multiple functions of the architecturally intricate Streptococcus pneumoniae β-galactosidase, BgaA.

Anirudh K Singh, Benjamin Pluvinage, Melanie A Higgins, Ankur B Dalia, Shireen A Woodiga, Matthew Flynn, Audrey R Lloyd, Jeffrey N Weiser, Keith A Stubbs, Alisdair B Boraston and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Identification ofJournal of proteome research · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Combining the In Silico and In Vitro Assays to IdentifyPharmaceuticals (Basel, Switzerland) · 2023
    Article
  10. Role ofFrontiers in cellular and infection microbiology · 2023
    Review
  11. Inhibition ofMicrobiology (Reading, England) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Molecular analysis of an enigmaticThe Journal of biological chemistry · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Anirudh K SinghCenter for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
Benjamin PluvinageBiochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Melanie A HigginsBiochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Ankur B DaliaDepartment of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Shireen A WoodigaCenter for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
Matthew FlynnCenter for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America; Department of Pediatrics, The Ohio State University, Columbus, Ohio, United States of America.
Audrey R LloydCenter for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America; Department of Pediatrics, The Ohio State University, Columbus, Ohio, United States of America.
Jeffrey N WeiserDepartment of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Keith A StubbsSchool of Biomedical, Biomolecular and Chemical Sciences, The University of Western Australia, Crawley, Western Australia, Australia.
Alisdair B BorastonBiochemistry and Microbiology, University of Victoria, Victoria, British Columbia, Canada.
Samantha J KingCenter for Microbial Pathogenesis, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America; Department of Pediatrics, The Ohio State University, Columbus, Ohio, United States of America.
Nationwide Children's Hospital · USUniversity of Victoria · CAUniversity of Pennsylvania · USThe Ohio State University · USUniversity of Western Australia · AU

Funding

Mechanisms of Pneumococcal AdherenceR01AI076341 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI KING, SAMANTHA JANE · 2009 to 2012
$1.3M
CIHR 86610NIAID NIH HHS 1R01 AI076341NIAID NIH HHS R01 AI076341
6 · The paper itself

Abstract

Bacterial cell-surface proteins play integral roles in host-pathogen interactions. These proteins are often architecturally and functionally sophisticated and yet few studies of such proteins involved in host-pathogen interactions have defined the domains or modules required for specific functions. Streptococcus pneumoniae (pneumococcus), an opportunistic pathogen that is a leading cause of community acquired pneumonia, otitis media and bacteremia, is decorated with many complex surface proteins. These include β-galactosidase BgaA, which is specific for terminal galactose residues β-1-4 linked to glucose or N-acetylglucosamine and known to play a role in pneumococcal growth, resistance to opsonophagocytic killing, and adherence. This study defines the domains and modules of BgaA that are required for these distinct contributions to pneumococcal pathogenesis. Inhibitors of β-galactosidase activity reduced pneumococcal growth and increased opsonophagocytic killing in a BgaA dependent manner, indicating these functions require BgaA enzymatic activity. In contrast, inhibitors increased pneumococcal adherence suggesting that BgaA bound a substrate of the enzyme through a distinct module or domain. Extensive biochemical, structural and cell based studies revealed two newly identified non-enzymatic carbohydrate-binding modules (CBMs) mediate adherence to the host cell surface displayed lactose or N-acetyllactosamine. This finding is important to pneumococcal biology as it is the first adhesin-carbohydrate receptor pair identified, supporting the widely held belief that initial pneumococcal attachment is to a glycoconjugate. Perhaps more importantly, this is the first demonstration that a CBM within a carbohydrate-active enzyme can mediate adherence to host cells and thus this study identifies a new class of carbohydrate-binding adhesins and extends the paradigm of CBM function. As other bacterial species express surface-associated carbohydrate-active enzymes containing CBMs these findings have broad implications for bacterial adherence. Together, these data illustrate that comprehending the architectural sophistication of surface-attached proteins can increase our understanding of the different mechanisms by which these proteins can contribute to bacterial pathogenesis.

Indexed as

Bacterial AdhesionBacterial Proteinsbeta-GalactosidaseCrystallography, X-RayEnzyme InhibitorsEpithelial CellsHost-Pathogen InteractionsHumansPneumococcal InfectionsProtein BindingProtein ConformationStreptococcus pneumoniaeBacterial Proteinsbeta-GalactosidaseEnzyme Inhibitors

Identifiers

PMID25210925
PMCPMC4161441
OpenAlexW2101820614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.